Longer Time Interval from Neoadjuvant Chemoradiation to Surgery is Associated with Poor Survival for Patients Without Clinical Complete Response in Oesophageal Cancer

BACKGROUND: The optimal interval between neoadjuvant therapy and oesophagectomy for oesophageal cancer remains controversial. METHODS: Patients with locally advanced oesophageal squamous cell carcinoma (ESCC) who received neoadjuvant chemoradiotherapy followed by oesophagectomy between June 2017 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Xin, Cheng, Chao, Cheng, Liang, Shang, Qi-Xin, Yang, Yu-Shang, Zeng, Xiao-Xi, Hu, Yang, Chen, Long-Qi, Yuan, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Thoracic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628481/
https://www.ncbi.nlm.nih.gov/pubmed/36322275
http://dx.doi.org/10.1245/s10434-022-12758-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628481/
https://www.ncbi.nlm.nih.gov/pubmed/36322275
http://dx.doi.org/10.1245/s10434-022-12758-9

Ejemplares similares